With key commercial cog Mark Mallon bound for Ironwood Pharmaceuticals' CEO spot, AstraZeneca is shaking up its corporate structure and revamping top management.
With key commercial cog Mark Mallon bound for Ironwood Pharmaceuticals' CEO spot, AstraZeneca is shaking up its corporate structure and revamping top management.